Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect (Q44563941)

From Wikidata
Jump to navigation Jump to search
scientific article published in September 2003
edit
Language Label Description Also known as
English
Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect
scientific article published in September 2003

    Statements

    Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect (English)
    0 references
    Hiroyuki Sugiyama

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit